Skip to main content
Erschienen in: The Indian Journal of Pediatrics 1/2013

01.03.2013 | Symposium on Chronic Noncommunicable Diseases and Children

Type 2 Diabetes Mellitus in Children and Youth

verfasst von: S. Ramkumar, Nikhil Tandon

Erschienen in: Indian Journal of Pediatrics | Sonderheft 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Type 2 diabetes mellitus (T2DM) which used to be a disease of adults is now seen commonly at an early age in children and adolescents. T2DM is now an important diagnostic consideration in children who present with signs and symptoms of diabetes. The emerging epidemic of obesity in children throughout the world and the resultant insulin resistance contributes to the increasing prevalence of T2DM in this population. The recommended treatment options include metformin and insulin. Optimal glycemic control is essential considering the lifelong nature of the disease and therefore, the increased risk of long term complications – both microvascular and macrovascular. This review article summarizes the classification, diagnosis, pathogenesis, management, complications and screening of T2DM in children, incorporating and contextualizing guidelines from various professional associations.
Literatur
1.
Zurück zum Zitat Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr. 2005;146:693–700.PubMedCrossRef Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr. 2005;146:693–700.PubMedCrossRef
2.
Zurück zum Zitat Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840–6.PubMedCrossRef Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840–6.PubMedCrossRef
3.
Zurück zum Zitat Trembley MS, Katzmarzyk PT, Wilms JD. Temporal trends in overweight and obesity in Canada, 1981–1996. Int J Obes. 2002;26:538–43.CrossRef Trembley MS, Katzmarzyk PT, Wilms JD. Temporal trends in overweight and obesity in Canada, 1981–1996. Int J Obes. 2002;26:538–43.CrossRef
4.
Zurück zum Zitat Khadilkar VV, Khadilkar AV, Cole TJ, Chiplon Kar SA, Pandit D. Overweight and obesity prevalence and body mass index trends in Indian children. Int J Obes. 2011;6:e216–34.CrossRef Khadilkar VV, Khadilkar AV, Cole TJ, Chiplon Kar SA, Pandit D. Overweight and obesity prevalence and body mass index trends in Indian children. Int J Obes. 2011;6:e216–34.CrossRef
5.
Zurück zum Zitat Marwaha RK, Tandon N, Ganie MA, et al. Nationwide reference data for height, weight and body mass index of Indian school children. Natl Med J India. 2011;24:269–77.PubMed Marwaha RK, Tandon N, Ganie MA, et al. Nationwide reference data for height, weight and body mass index of Indian school children. Natl Med J India. 2011;24:269–77.PubMed
6.
Zurück zum Zitat Agarwal DK, Agarwal KN, Upadhyay SK, Mittal R, Prakash R, Rai S. Physical and sexual growth pattern of affluent Indian children from 5–18 years of age. Indian Pediatr. 1992;29:1203–82. Agarwal DK, Agarwal KN, Upadhyay SK, Mittal R, Prakash R, Rai S. Physical and sexual growth pattern of affluent Indian children from 5–18 years of age. Indian Pediatr. 1992;29:1203–82.
7.
Zurück zum Zitat The Writing Group for the SEARCH for Diabetes in Youth Study Group. Incidence of diabetes in youth in the United States. JAMA. 2007;297:2716–24.CrossRef The Writing Group for the SEARCH for Diabetes in Youth Study Group. Incidence of diabetes in youth in the United States. JAMA. 2007;297:2716–24.CrossRef
8.
Zurück zum Zitat Pozzilli P, Guglielmi C, Caprio S, Buzzetti R. Obesity, autoimmunity, and double diabetes in youth. Diabetes Care. 2011;34:S166–70.PubMedCrossRef Pozzilli P, Guglielmi C, Caprio S, Buzzetti R. Obesity, autoimmunity, and double diabetes in youth. Diabetes Care. 2011;34:S166–70.PubMedCrossRef
9.
Zurück zum Zitat Balasubramanyam A, Yajnik CS, Tandon N. Non-traditional forms of diabetes worldwide: Implications for translational investigation. Trans Endocrinol Metab. 2011;2:43–67. Balasubramanyam A, Yajnik CS, Tandon N. Non-traditional forms of diabetes worldwide: Implications for translational investigation. Trans Endocrinol Metab. 2011;2:43–67.
10.
Zurück zum Zitat Fajans SS, Bell GI. MODY – history, genetics, pathophysiology and clinical decision making. Diabetes Care. 2011;34:1878–84.PubMedCrossRef Fajans SS, Bell GI. MODY – history, genetics, pathophysiology and clinical decision making. Diabetes Care. 2011;34:1878–84.PubMedCrossRef
11.
Zurück zum Zitat Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith G. Type 2 diabetes in the child and adolescent. ISPAD. Pediatr Diabetes. 2009;10:17–32.PubMedCrossRef Rosenbloom AL, Silverstein JH, Amemiya S, Zeitler P, Klingensmith G. Type 2 diabetes in the child and adolescent. ISPAD. Pediatr Diabetes. 2009;10:17–32.PubMedCrossRef
12.
Zurück zum Zitat American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34:S62–9.CrossRef American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2011;34:S62–9.CrossRef
13.
Zurück zum Zitat Nowicka P, Santoro N, Liu H, et al. Utility of Hemoglobin A1c for diagnosing prediabetes and diabetes in obese children and adolescents. Diabetes Care. 2011;34:1306–11.PubMedCrossRef Nowicka P, Santoro N, Liu H, et al. Utility of Hemoglobin A1c for diagnosing prediabetes and diabetes in obese children and adolescents. Diabetes Care. 2011;34:1306–11.PubMedCrossRef
14.
Zurück zum Zitat Dunaif A. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774–880. Dunaif A. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774–880.
15.
Zurück zum Zitat Marchal CL, Arslanian S, Cutfield W, et al. Insulin resistance in children: Consensus, perspective, and future directions. J Clin Endocrinol Metab. 2010;95:5189–98. Marchal CL, Arslanian S, Cutfield W, et al. Insulin resistance in children: Consensus, perspective, and future directions. J Clin Endocrinol Metab. 2010;95:5189–98.
16.
Zurück zum Zitat Matthaei S, Stumvoll M, Keller M, Häring HC. Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev. 2000;21:585–618.PubMedCrossRef Matthaei S, Stumvoll M, Keller M, Häring HC. Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev. 2000;21:585–618.PubMedCrossRef
17.
Zurück zum Zitat Chauhan G, Spurgeon CJ, Tabassum R, et al. Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1on the risk of type 2 diabetes in 5,164 Indians. Diabetes. 2010;59:2068–74. Chauhan G, Spurgeon CJ, Tabassum R, et al. Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1on the risk of type 2 diabetes in 5,164 Indians. Diabetes. 2010;59:2068–74.
18.
Zurück zum Zitat Buzzetti R, Petrone A, Caiazzo AM, et al. PPAR-ϒ2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity. Pediatr Res. 2005;57:138–40.PubMedCrossRef Buzzetti R, Petrone A, Caiazzo AM, et al. PPAR-ϒ2 Pro12Ala variant is associated with greater insulin sensitivity in childhood obesity. Pediatr Res. 2005;57:138–40.PubMedCrossRef
19.
Zurück zum Zitat Viswanathan M, Mohan V, Snehalatha C, Ramachandran A. High prevalence of type 2 (non-insulin-dependent) diabetes among the offspring of conjugal type 2 diabetic parents in India. Diabetologia. 1985;28:907–10.PubMedCrossRef Viswanathan M, Mohan V, Snehalatha C, Ramachandran A. High prevalence of type 2 (non-insulin-dependent) diabetes among the offspring of conjugal type 2 diabetic parents in India. Diabetologia. 1985;28:907–10.PubMedCrossRef
20.
Zurück zum Zitat Morales AE, Rosenbloom AL. Death caused by hyperglycemic hyperosmolar state at the onset of type 2 diabetes. J Pediatr. 2004;144:270–3.PubMedCrossRef Morales AE, Rosenbloom AL. Death caused by hyperglycemic hyperosmolar state at the onset of type 2 diabetes. J Pediatr. 2004;144:270–3.PubMedCrossRef
21.
Zurück zum Zitat Pinhas-Hamiel O, Zeitler P. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet. 2007;369:1823–31.PubMedCrossRef Pinhas-Hamiel O, Zeitler P. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet. 2007;369:1823–31.PubMedCrossRef
22.
Zurück zum Zitat Guz M, Garcĭa-Maado R, Garcĭa-Valerio Y, et al. Low adiponectin levels predict type 2 diabetes in mexican children. Diabetes Care. 2004;27:1451–3. Guz M, Garcĭa-Maado R, Garcĭa-Valerio Y, et al. Low adiponectin levels predict type 2 diabetes in mexican children. Diabetes Care. 2004;27:1451–3.
23.
Zurück zum Zitat Gungor N, Thompson T, Sutton-Tyrell K, Janosky J, Arslanian S. Early signs of cardiovascular disease in youth with obesity and type 2 diabetes. Diabetes Care. 2005;28:1219–21. Gungor N, Thompson T, Sutton-Tyrell K, Janosky J, Arslanian S. Early signs of cardiovascular disease in youth with obesity and type 2 diabetes. Diabetes Care. 2005;28:1219–21.
24.
Zurück zum Zitat Tabassum R, Yuvraj M, Dwivedi OP, et al. Common variants of IL6, LEPR and PBEF1 are associated with obesity in Indian children. Diabetes. 2012;61:626–31.PubMedCrossRef Tabassum R, Yuvraj M, Dwivedi OP, et al. Common variants of IL6, LEPR and PBEF1 are associated with obesity in Indian children. Diabetes. 2012;61:626–31.PubMedCrossRef
25.
Zurück zum Zitat Mahajan A, Tabassum R, Chavali S, et al. High-sensitivity C-reactive protein levels and type 2 diabetes in urban North Indians. J Clin Endocrinol Metab. 2009;94:2123–7.PubMedCrossRef Mahajan A, Tabassum R, Chavali S, et al. High-sensitivity C-reactive protein levels and type 2 diabetes in urban North Indians. J Clin Endocrinol Metab. 2009;94:2123–7.PubMedCrossRef
26.
Zurück zum Zitat Marwaha RK, Khadgawat R, Tandon N, et al. Reference intervals of serum lipid profile in healthy Indian school children and adolescents. Clin Biochem. 2011;44:760–6.PubMedCrossRef Marwaha RK, Khadgawat R, Tandon N, et al. Reference intervals of serum lipid profile in healthy Indian school children and adolescents. Clin Biochem. 2011;44:760–6.PubMedCrossRef
28.
Zurück zum Zitat Jones KL, Arslanian S, Peterokova VA, et al. Effect of metformin in pediatric patients with type 2 diabetes: A randomized controlled trial. Diabetes Care. 2002;25:89–94. Jones KL, Arslanian S, Peterokova VA, et al. Effect of metformin in pediatric patients with type 2 diabetes: A randomized controlled trial. Diabetes Care. 2002;25:89–94.
29.
Zurück zum Zitat Lipska KJ, Bailey CJ, Inzucchi SE. Use of metformin in the setting of mild-to-moderate renal insufficiency. Diabetes Care. 2011;34:1431–7.PubMedCrossRef Lipska KJ, Bailey CJ, Inzucchi SE. Use of metformin in the setting of mild-to-moderate renal insufficiency. Diabetes Care. 2011;34:1431–7.PubMedCrossRef
30.
Zurück zum Zitat TODAY Study Group, Zeitler P, Epstein L, Grey M, et al. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes. 2007;8:74–87. TODAY Study Group, Zeitler P, Epstein L, Grey M, et al. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes. 2007;8:74–87.
31.
Zurück zum Zitat TODAY Study Group, Zeitler P, Epstein L, Grey M, et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012;366:2247–56. TODAY Study Group, Zeitler P, Epstein L, Grey M, et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012;366:2247–56.
32.
Zurück zum Zitat Gottschalk M, Danne T, Vlajnic A, Cara JF. Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: A randomized, single-blind comparative study. Diabetes Care. 2007;30:790–4. Gottschalk M, Danne T, Vlajnic A, Cara JF. Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: A randomized, single-blind comparative study. Diabetes Care. 2007;30:790–4.
33.
Zurück zum Zitat American Diabetes Association. Executive summary: Standards of medical care in diabetes—2011. Diabetes Care. 2011;34:S4–10. American Diabetes Association. Executive summary: Standards of medical care in diabetes—2011. Diabetes Care. 2011;34:S4–10.
34.
Zurück zum Zitat Inge TH, Miyano G, Bean J, et al. Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents. Pediatrics. 2009;123:214–22.PubMedCrossRef Inge TH, Miyano G, Bean J, et al. Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents. Pediatrics. 2009;123:214–22.PubMedCrossRef
35.
Zurück zum Zitat Nadler EP, Reddy S, Isenalumhe A, et al. Laparoscopic adjustable gastric banding for morbidly obese adolescence affects android fat loss, resolution comorbidities, and improved metabolic status. J Am Coll Surg. 2009;209:638–44.PubMedCrossRef Nadler EP, Reddy S, Isenalumhe A, et al. Laparoscopic adjustable gastric banding for morbidly obese adolescence affects android fat loss, resolution comorbidities, and improved metabolic status. J Am Coll Surg. 2009;209:638–44.PubMedCrossRef
36.
Zurück zum Zitat Brien PO, Sawyer SM, Laurie C, et al. Laparoscopic adjustable gastric banding in severely obese adolescent. JAMA. 2010;303:519–26.CrossRef Brien PO, Sawyer SM, Laurie C, et al. Laparoscopic adjustable gastric banding in severely obese adolescent. JAMA. 2010;303:519–26.CrossRef
37.
Zurück zum Zitat American Diabetes Association. Type 2 diabetes in children and adolescents (Consensus Statement). Diabetes Care. 2000;23:381–9.CrossRef American Diabetes Association. Type 2 diabetes in children and adolescents (Consensus Statement). Diabetes Care. 2000;23:381–9.CrossRef
38.
Zurück zum Zitat American Diabetes Association. Type 2 diabetes in children and adolescents. Pediatrics. 2000;105:671–80.CrossRef American Diabetes Association. Type 2 diabetes in children and adolescents. Pediatrics. 2000;105:671–80.CrossRef
39.
Zurück zum Zitat Shah S, Kublaoui BM, Oden JD, White PC. Screening for type 2 diabetes in obese youth. Pediatrics. 2009;124:573–9. Shah S, Kublaoui BM, Oden JD, White PC. Screening for type 2 diabetes in obese youth. Pediatrics. 2009;124:573–9.
Metadaten
Titel
Type 2 Diabetes Mellitus in Children and Youth
verfasst von
S. Ramkumar
Nikhil Tandon
Publikationsdatum
01.03.2013
Verlag
Springer-Verlag
Erschienen in
Indian Journal of Pediatrics / Ausgabe Sonderheft 1/2013
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-013-0962-6

Weitere Artikel der Sonderheft 1/2013

The Indian Journal of Pediatrics 1/2013 Zur Ausgabe

Symposium on Chronic Noncommunicable Diseases and Children

Childhood Obesity and the Metabolic Syndrome in Developing Countries

Symposium on Chronic NonCommunicable Diseases and Children

Cardiovascular Disease Risk Factors: A Childhood Perspective

Symposium on Chronic Noncommunicable Diseases and Children

Fetal Programming and the Risk of Noncommunicable Disease

Symposium on Chronic NONCOMMUNICABLE Diseases and Children

The Clinical Treatment of Childhood Obesity

Symposium on Chronic Noncommunicable Diseases and Children

Lifestyle Changes and Childhood Asthma

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.